Mckesson Corporation

Research Mckesson Corporation (MCK) on Bullrun: valuation model: fairly valued, market cap USD 89.86B, P/E 19.4, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerMCK
ExchangeNYSE
CountryUnited States
SectorHealthcare
IndustryMedical Distribution
CurrencyUSD
Valuation signalfairly valued
Market capUSD 89.86B
P/E19.4
Dividend yield0.4%
Financial periodFY2026
RevenueUSD 403.43B
Revenue growth12.4%
Net incomeUSD 4.76B
Free cash flowUSD 5.72B
Gross margin3.6%

Valuation Snapshot

Bullrun's latest valuation model marks Mckesson Corporation as fairly valued; latest market cap is USD 89.86B; P/E is 19.4; dividend yield is 0.4%.

About Mckesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions;

Frequently asked questions

Is Mckesson Corporation overvalued or undervalued?

Bullrun's valuation model currently marks Mckesson Corporation as fairly valued.

What is Mckesson Corporation's market cap?

Mckesson Corporation's market capitalization is USD 89.86B.

What is Mckesson Corporation's P/E ratio?

Mckesson Corporation's price-to-earnings (P/E) ratio is 19.4.

Does Mckesson Corporation pay a dividend?

Mckesson Corporation has a dividend yield of 0.4%.